The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Signal Transduction | Differentiation & Death
The EMBO Journal (2006) 25, 1883–1894, doi:10.1038/sj.emboj.7601077
Published online 6 April 2006
Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2
Ekaterina Gresko1, 6, Ana Roscic1, Stefanie Ritterhoff1, Anton Vichalkovski2, Giannino del Sal3, 4 and M Lienhard Schmitz5
1 Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland
2 Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
3 Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie (LNCIB), Area Science Park, Trieste, Italy
4 Dipartimento di Biochimica Biofisica Chimica delle Macromolecole, Trieste, Italy
5 Institute of Biochemistry, Medical Faculty, Justus-Liebig-University, Giessen, Germany

To whom correspondence should be addressed
M Lienhard Schmitz, Institute of Biochemistry, Medical Faculty, Justus-Liebig-University, Friedrichstrasse 24, 35392 Giessen, Germany. Tel.: +49 641 994 7570; Fax: +49 641 994 7589; E-mail: lienhard.schmitz@biochemie.med.uni-giessen.de

6 Present address: Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4002 Basel, Switzerland

Received 9 August 2005; Accepted 9 March 2006; Published online 6 April 2006.
Abstract
The serine/threonine kinase HIPK2 phosphorylates the p53 protein at Ser 46, thus promoting p53-dependent gene expression and subsequent apoptosis. Here, we show that DNA damaging chemotherapeutic drugs cause degradation of endogenous HIPK2 dependent on the presence of a functional p53 protein. Early induced p53 allows caspase-mediated cleavage of HIPK2 following aspartic acids 916 and 977. The resulting C-terminally truncated HIPK2 forms show an enhanced induction of the p53 response and cell death, thus allowing the rapid amplification of the p53-dependent apoptotic program during the initiation phase of apoptosis by a regulatory feed-forward loop. The active HIPK2 fragments are further degraded during the execution and termination phase of apoptosis, thus ensuring the occurrence of HIPK2 signaling only during the early phases of apoptosis induction.
Keywords: apoptosis, caspases, HIPK2, p53
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Caspase activity sows the seeds of neuronal death

Nature Cell Biology News and Views (01 Jun 1999)

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2006 by the European Molecular Biology Organization